ResearchSpace

Statistical studies for SNP association in acute coronary syndrome ex vivo use of agonists and nanoparticles

Show simple item record

dc.contributor.author Das Roy, P
dc.contributor.author Basu, C
dc.contributor.author Das, Sonali
dc.contributor.author Das Gupta, A
dc.date.accessioned 2014-08-15T12:56:42Z
dc.date.available 2014-08-15T12:56:42Z
dc.date.issued 2014-06
dc.identifier.citation Das Roy, P, Basu, C, Das, S and Das Gupta, A. 2014. Statistical studies for SNP association in acute coronary syndrome ex vivo use of agonists and nanoparticles. Calcutta Statistical Association Bulletin, pp 221-230 en_US
dc.identifier.uri http://hdl.handle.net/10204/7584
dc.description Copyright: 2014 Calcutta Statistical Association Bulletin. This is the pre/post print version. The definitive version is Published in Calcutta Statistical Association Bulletin, pp 221-230 en_US
dc.description.abstract In this paper we apply statistical classification techniques to a case-control study. The data analysed relates to Acute Coronary Syndrome (ACS). We discuss an adaptation of the Naijve Bayes method, and assess the results using an analysis of deviance based approach. Analysis of deviance is used to rank the driver variables, such as phenotype and genotype variables to their relative contribution to classify a new case into one of ACS or non-ACS group. Results from the case study reveal that a combination of Single Nucleotide Polymorphism 2 and Single Nucleotide Polymorphism 4 is the most important, and the aggregation of platelets on addition of Adenosine-di-phosphate along with nano particles the next most important factors in classifying an unseen patient into one of the two groups. Some limitations and future analyses are also discussed. en_US
dc.language.iso en en_US
dc.publisher Calcutta Statistical Association Bulletin en_US
dc.relation.ispartofseries Workflow;13197
dc.subject Acute Coronary Syndrome en_US
dc.subject ACS en_US
dc.subject Single Nucleotide Polymorphism en_US
dc.subject SNP en_US
dc.subject Heart attacks en_US
dc.title Statistical studies for SNP association in acute coronary syndrome ex vivo use of agonists and nanoparticles en_US
dc.type Article en_US
dc.identifier.apacitation Das Roy, P., Basu, C., Das, S., & Das Gupta, A. (2014). Statistical studies for SNP association in acute coronary syndrome ex vivo use of agonists and nanoparticles. http://hdl.handle.net/10204/7584 en_ZA
dc.identifier.chicagocitation Das Roy, P, C Basu, Sonali Das, and A Das Gupta "Statistical studies for SNP association in acute coronary syndrome ex vivo use of agonists and nanoparticles." (2014) http://hdl.handle.net/10204/7584 en_ZA
dc.identifier.vancouvercitation Das Roy P, Basu C, Das S, Das Gupta A. Statistical studies for SNP association in acute coronary syndrome ex vivo use of agonists and nanoparticles. 2014; http://hdl.handle.net/10204/7584. en_ZA
dc.identifier.ris TY - Article AU - Das Roy, P AU - Basu, C AU - Das, Sonali AU - Das Gupta, A AB - In this paper we apply statistical classification techniques to a case-control study. The data analysed relates to Acute Coronary Syndrome (ACS). We discuss an adaptation of the Naijve Bayes method, and assess the results using an analysis of deviance based approach. Analysis of deviance is used to rank the driver variables, such as phenotype and genotype variables to their relative contribution to classify a new case into one of ACS or non-ACS group. Results from the case study reveal that a combination of Single Nucleotide Polymorphism 2 and Single Nucleotide Polymorphism 4 is the most important, and the aggregation of platelets on addition of Adenosine-di-phosphate along with nano particles the next most important factors in classifying an unseen patient into one of the two groups. Some limitations and future analyses are also discussed. DA - 2014-06 DB - ResearchSpace DP - CSIR KW - Acute Coronary Syndrome KW - ACS KW - Single Nucleotide Polymorphism KW - SNP KW - Heart attacks LK - https://researchspace.csir.co.za PY - 2014 T1 - Statistical studies for SNP association in acute coronary syndrome ex vivo use of agonists and nanoparticles TI - Statistical studies for SNP association in acute coronary syndrome ex vivo use of agonists and nanoparticles UR - http://hdl.handle.net/10204/7584 ER - en_ZA


Files in this item

This item appears in the following Collection(s)

Show simple item record